Electrocardiographical changes in a patient with intracerebral thalamic hemorrhage

Authors

  • Raúl Joaquín Varela García Hospital General Docente “Dr. Juan Bruno Zayas Alfonso”, Santiago de Cuba http://orcid.org/0000-0002-1825-0097
  • Yamilé Castillo Planas Hospital General Docente “Dr. Juan Bruno Zayas Alfonso”, Santiago de Cuba
  • Maricel Linares Tamayo Hospital General Docente “Dr. Juan Bruno Zayas Alfonso”, Santiago de Cuba

Keywords:

elderly, intracerebralthalamic hemorrhage, acute coronary syndrome, electrocardiographic change.

Abstract

The case report of a 67 year-old patient is presented who was admitted in the Neurology Service of "Dr. Juan Bruno Zayas Alfonso" Teaching General Hospital, Santiago de Cuba, with neurological clinical manifestations and high values of blood pressure, besides electrocardiographical changes similar to myocardial ischemia. As there was absence of precordial pain or other clinical signs of myocardial  ischemia,  it was impossible to diagnose an acute coronary syndrome, reason why a simple skull on-line axial tomography was carried out which result confirmed that it was an intracerebralthalamic hemorrhage. Finally, the biomarkers of myocardial necrosis were negative. 

Downloads

Download data is not yet available.

Author Biography

Raúl Joaquín Varela García, Hospital General Docente “Dr. Juan Bruno Zayas Alfonso”, Santiago de Cuba

medico especialista en MGI y Cardiologia, profesor instructor, master en urgencias médicas, cardiologo del servicio de cardiologia hospital Juan B. Zayas Alfonso de Santiago de Cuba

References

1. Braunwald E, Libby R, Bonow DL, Mann DP. Zipes: Braunwald. Tratado de Cardiología. Texto de medicina cardiovascular. 10 ed. Barcelona: Elsevier; 2015. p. 143-6.

2. Ropper A, Samuels M, Klein J. Adams RD and Victor´s. Principles of Neurology. 10th. New York: McGraw-Hill; 2014.p.837-44.

3. Kongbunkiat K, Kasemsap N, Travanichakul S, Thepsuthammarat K, Tiamkao S, Sawanyawisuth K. Hospital mortality from atrial fibrillation associated with ischemic stroke: a national data report. Int J Neurosci. 2015;125(12):924-8.

4. Hjalmarsson C, Bergfeldt L, Bokemark L, Manhem K, Andersson B. Electrocardiographic abnormalities and elevated cTNT at admission for intracerebral hemorrhage: predictors for survival? Ann Noninvasive Electrocardiol. 2013; 18(5):441-9.

5. Junttila E, Vaaram M, Koskenkari J, Ohtonen P, Karttunen A, Raatikainen P, et al. Repolarization abnormalities in patients with subarachnoid and intracerebral hemorrhage: predisposing factors and association with outcome. Anesth Analg. 2013;116(1):190-7.

6. Popescu D, Laza C, Mergeani A, Alexandu Bajenaru O, Anca Antochi F. Lead electrocardiogram changes after supratentorial intracerebral hemorrhage. Maedica (Buchar). 2012; 7(4):290-4.

7. Manea MM, Comsa M, Minca A, Dragos D, Popa C. Brain-heart axis-Review Article. Journal of Medicine and Life. 2015; 8(3):266-71.

8. Pérez Fernández A, Mederos Hernández J. Alteraciones electrocardiográficas en pacientes con hemorragia intracerebral espontánea. Rev Habanera Cien Méd. 2016; 15(1):27-39.

9. Malik S, Abdul Sattar R, Shah S, Rehman H, Ismail MA. Frequency of QTc prolongation in patients with hemorrhagic stroke. J Ayub Med Coll Abbottabad. 2013; 25(3-4):75-7.

10. Vepsäläinen T, Laakso M, Lehto S. Prolonged P wave duration predicts stroke mortality among type 2 diabetic patients with prevalent non-major macrovascular disease. BMC Cardiovasc Disord. 2014; 14(1):168.

Downloads

Published

2017-10-12

How to Cite

1.
Varela García RJ, Castillo Planas Y, Linares Tamayo M. Electrocardiographical changes in a patient with intracerebral thalamic hemorrhage. MEDISAN [Internet]. 2017 Oct. 12 [cited 2025 Jun. 4];21(10). Available from: https://medisan.sld.cu/index.php/san/article/view/1461

Issue

Vol. 21 No. 10 (2017): MEDISAN

Section

Case Reports

License

All the articles can be downloaded or read for free. The journal does not charge any amount of money to the authors for the reception, edition or the publication of the articles, making the whole process completely free. Medisan has no embargo period and it is published under the license of Creative Commons, International Non Commercial Recognition 4.0, which authorizes the copy, reproduction and the total or partial distribution of the articles in any format or platform, with the conditions of citing the source of information and not to be used for profitable purposes.